Joe Wiley. Amryt

Com­ing out of Chap­ter 11, Aege­ri­on jumps in­to wel­come arms of Irish phar­ma with big plans, fresh $60M for its drugs

Am­ryt Phar­ma didn’t make much of a splash in May when it struck a deal to ac­quire Nov­e­l­ion’s Aege­ri­on sub­sidiary, ab­sorb­ing two com­mer­cial drugs and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.